Source: Hadassah University Medical Center
Date: March 31, 2010
Summary:
Researchers at Jerusalem’s Hadassah University Medical Center have developed a novel strategy to derive and culture human embryonic stem cells in suspension. This breakthrough may be the key to developing systems to manufacture the enormous quantities of stem cells required to treat millions of patients.
The research results, published in the recent edition of the prestigious scientific journal Nature Biotechnology, demonstrated that human embryonic stem cell lines can be developed and grown while floating within a cultivation medium. This obviates the need to seed the embryonic stem cells over a substrate – the current methodology – which is very labor intensive and can produce limited quantities of stem cells.
